Market Exclusive

Bio-Techne Corp (NASDAQ:TECH) reported earnings of $0.80 per share missing Walls Streets expectations.

Bio-Techne Corp (NASDAQ:TECH) reported Q4 2017 earnings this Morning, coming in at $0.80 per share, missing Wall Street’s estimates of $0.99 per Share. Revenue for the quarter came in at $156.60 million beating analyst estimates of $150.25 million

Analyst Coverage For Bio-Techne Corp (NASDAQ:TECH)
These are 2 Hold Ratings, 4 Buy Ratings .
The current consensus rating for Bio-Techne Corp (NASDAQ:TECH) is Buy (Score: 2.67) with a consensus target price of $121.25 , a potential (4.32% upside)Recent Insider Trading for Bio-Techne Corp (NASDAQ:TECH)

Dividend History for Bio-Techne Corp (NASDAQ:TECH)

Recent Trading for Bio-Techne Corp (NASDAQ:TECH) Shares of Bio-Techne Corp closed the previous trading session at 116.39 up +0.16 0.14% with 146,798 shares trading hands.

Exit mobile version